Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases - Lifestyle

Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

July 15, 2026

Press Releases - Lifestyle

LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026

July 15, 2026

Press Releases - Lifestyle

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

July 14, 2026

Press Releases - Lifestyle

INVESTOR DEADLINE ALERT: PicS N.V. (PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

July 14, 2026

Press Releases

West Tennessee Bank Breaks Ground on Permanent Germantown Branch

July 14, 2026

Press Releases - Lifestyle

Catherine Hershey Schools for Early Learning Opens First Lancaster County Center

July 14, 2026

Press Releases - Lifestyle

Space for Humanity’s “Take Off in Zero-G” to Inspire the Next Generation of Global Space Communicators

July 14, 2026

Press Releases

CU SoCal Team Members and Members Rally to Support Local Families Through Diaper Drive

July 14, 2026

Press Releases - Lifestyle

Global AI Cinema Launches Global Initiative to Define Cinema in the Age of AI

July 14, 2026

Press Releases - Lifestyle

Sandbox VR Continues to Expand Across Colorado with a New Denver Venue

July 14, 2026

Page 2095 of 5718 Prev 1 … 2,094 2,095 2,096 … 5,718 Next

No Result

View All Result

Home

Cision PR Newswire

Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

INVESTOR DEADLINE ALERT: PicS N.V. (PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

West Tennessee Bank Breaks Ground on Permanent Germantown Branch

Catherine Hershey Schools for Early Learning Opens First Lancaster County Center

Space for Humanity’s “Take Off in Zero-G” to Inspire the Next Generation of Global Space Communicators

CU SoCal Team Members and Members Rally to Support Local Families Through Diaper Drive

Global AI Cinema Launches Global Initiative to Define Cinema in the Age of AI

Sandbox VR Continues to Expand Across Colorado with a New Denver Venue

Recommended

Revision Skincare® Appoints Derrick Booker as Chief Marketing Officer

McCormick Releases 2025 Purpose-led Performance Report, Strengthening Business Resilience and Long-Term Value Through Measurable Progress Across Its Commitments

Popular News

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Portillo’s Inc. (NASDAQ: PTLO) — Investors Who Suffered Losses Are Encouraged to Contact the Firm.

EFICYENT to Join Banks and Fintech Companies at Singapore FinTech Festival 2026

61% of Older Workers Already Tapping Retirement Savings to Cover Expenses

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

IEHP postpones opening of San Bernardino Community Wellness Center

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands